Page 187 - Pagetit
P. 187

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Tsuang MT et al. (1999) Genetic and environmental influences on transitions in
                   drug use. Behavior Genetics, 29:473–479.
                   Tsuang MT et al. (2001) The Harvard Twin Study of Substance Abuse: what we
                   have learned. Harvard Review of Psychiatry, 9:267–279.
                   Tyndale RF, Sellers EM (2002) Genetic variation in CYP2A6-mediated nicotine
                   metabolism alters smoking behavior. Therapeutic Drug Monitoring, 24:163–171.

                   Tyndale RF, Droll KP, Sellers EM (1997) Genetically deficient CYP2D6 metabolism
                   provides protection against oral opiate dependence. Pharmacogenetics, 7:375–
                   379.
                   Tyndale RF et al. (2002) CYP2A6 lower activity genotypes are associated with
                   decreased risk for smoking and varying frequency among ethnic groups. In:
                   Microsomes and drug oxidations. Sapporo, Japan: International Symposium on
                   Microsomes and Drug Oxidations:150.
                   Uchtenhagen A (2000a) Determinanten für drogenkonsum und –abhängigkeit.
                   [Determinants of drug use and addiction.] In: Uchtenhagen A, Zieglgänsberger W,
                   eds. Suchtmedizin: konzepte, strategien und therapeutsches management.
                   [Addiction medicine: concepts, strategies and therapeutic management.] Munich,
                   Urban & Fischer Verlag:193–195.
                   Uchtenhagen A (2000b) Risikofaktoren und schutzfaktoren: eine übersicht. [Risk
                   and protective factors: an overview.] In: Uchtenhagen A, Zieglgänsberger W, eds.
                   Suchtmedizin: konzepte, strategien und therapeutsches management. [Addiction
                   medicine: concepts, strategies and therapeutic management.] Munich, Urban
                   &Fischer Verlag:195–198.
                   Ueno Y et al. (1996) Effect of the cytochrome P450IIE1 genotype on ethanol
                   elimination rate in alcoholics and control subjects. Alcoholism: Clinical and
                   Experimental Research, 20(Suppl. 1):A17–A21.
                   Uhl GR et al. (1998) Dopaminergic genes and substance abuse. Advances in
                   Pharmacology, 42:1024–1032.
                   Vaccarino FJ (1994) Nucleus accumbens dopamine-CCK interactions in psycho-
                   stimulant reward and related behaviors. Neuroscience and Biobehavioral Reviews,
                   18:207–214.
                   Vandenbergh DJ et al. (1997) High-activity catechol-O-methyltransferase allele
                   is more prevalent in polysubstance abusers. American Journal of Medical Genetics,
                   74:439–442.
                   Vandenbergh DJ et al. (2000) Long forms of the dopamine receptor (DRD4) gene
                   VNTR are more prevalent in substance abusers: no interaction with functional
                   alleles of the catechol-o-methyltransferase (COMT) gene. American Journal of
                   Medical Genetics, 96:678–683.
                   van den Bree MB, Svikis DS, Pickens RW (1998a) Genetic influences in antisocial
                   personality and drug use disorders. Drug and Alcohol Dependence, 49:177–187.
                   van den Bree MB et al. (1998b) Genetic analysis of diagnostic systems of
                   alcoholism in males. Biological Psychiatry, 43:139–145.
                   Vanyukov MM, Tarter RE (2000) Genetic studies of substance abuse. Drug and
                   Alcohol Dependence, 59:101–123.


                                                  166




          Chapter_5                166                             19.1.2004, 11:46
   182   183   184   185   186   187   188   189   190   191   192